The recipient was a 50-year-old man with blood type O who was referred to our department for a pre-emptive ABO-incompatible kidney transplantation (KTx), with his wife as the donor whose blood was type A. However, both of the T and B cell complement-dependent crossmatch and flow cytometric crossmatch tests showed positive results. Even though donor-specific antibodies were negative by Luminex, we did not recommend transplantation and he had received dialysis therapy for 3 years. We conducted a re-evaluation of crossmatch tests. IgM and anti-B antibody were eliminated from the recipient's sera by the processing with dithiothreitol and the absorption mixing type B red blood cells. However, crossmatch tests still showed positive. Then, we eliminated anti-A antibody by the absorption mixing type A red blood cells. T- and B-cell crossmatch tests turned to negative, suggesting anti-A antibody in the recipient's sera binds to type A substance onto the donor's T and B lymphocytes. The recipient received an ABO-incompatible KTx with our standard desensitization therapy. Immediate graft function was achieved without any rejection.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.transproceed.2025.02.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Undiagnosed Lymphoma Detected During Routine Histocompatibility Crossmatch: Three Case Reports.
Am J Transplant
March 2025
Histocompatibility and Infectious Disease Testing Laboratory, Gift of Hope Organ & Tissue Donor Network, Itasca, IL; Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, MI. Electronic address:
Unexpected transmission of donor-derived diseases, including infections and malignancies, through organ transplantation are occasionally observed and reported. Subclinical, or otherwise undiagnosed, hematological malignancies in potential donors are rare events and typically not identifiable via standard donor evaluation or laboratory testing. Flow cytometric crossmatching (FCXM) is a specialized assay routinely performed in clinical histocompatibility laboratories for the evaluation of immunological compatibility between the recipients and the organ donors through the detection of donor-specific antibodies.
View Article and Find Full Text PDFBackground: There has been a large number of immigration to Turkey after 2011, and in the past 13 years, a mixed population has been formed with both the transition to Turkish citizenship and high fertility rates. Along with numerous human migrations, gene trait transfer also occurs. This study aimed to investigate the effects of migration on blood group changes in Turkey by determining the blood group distribution of Turkish citizens living in Turkey, the blood group distribution of foreign nationals coming to Turkey, and the blood group distribution of 0-year-old babies born in the last four years.
View Article and Find Full Text PDFMachine learning enhanced immunologic risk assessments for solid organ transplantation.
Sci Rep
March 2025
Department of Mathematics, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
The purpose of this study was to enhance the prediction of solid-organ recipient and donor crossmatch compatibility by applying machine learning (ML). Prediction of crossmatch compatibility is complex and requires an understanding of the recipient and donor human leukocyte antigen (HLA) alleles and recipient HLA antibodies. An HLA allele imputation system that converts HLA antigens to alleles was developed to enhance the prediction's performance.
View Article and Find Full Text PDF[Serological and Molecular Biological Characteristics of AB Blood Group and Transfusion Strategies].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
February 2025
Department of Blood Transfusion，Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
Objective: To analyze the serological and molecular biological characteristics of 5 patients with AB blood group, and to explore the safe transfusion strategy.
Methods: Serological identification of the samples' blood group was performed using anti-A, anti-B, anti-D, anti-A1, anti-H typing reagents and ABO reagent erythrocytes. Molecular biological identification of the samples' blood group was performed using PCR-SSP or gene sequencing.
A Case of ABO-Incompatible Kidney Transplantation for a False-Positive T and B-Cell Crossmatch Test Due to Anti-A Antibodies.
Transplant Proc
February 2025
Division of Urology, Department of Regenerative & Transplant Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
The recipient was a 50-year-old man with blood type O who was referred to our department for a pre-emptive ABO-incompatible kidney transplantation (KTx), with his wife as the donor whose blood was type A. However, both of the T and B cell complement-dependent crossmatch and flow cytometric crossmatch tests showed positive results. Even though donor-specific antibodies were negative by Luminex, we did not recommend transplantation and he had received dialysis therapy for 3 years.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!